Antimicrobial stewardship is, in short, defined as the "right drug, right dose and right duration"; however, in recent years emphasis on the duration has been highlighted in many studies. This program looks to serve as a primer for disease states which can be effectively managed with short course antimicrobial therapy and in contrast outline when extended courses of antimicrobial therapy are more appropriate. Moreover, this session seeks to remind clinicians that short course therapy is also applicable to pediatric patients and will provide an overview of available data in this patient population. This session will consist of three speakers: the first two who will present on overview on the evidence supporting short course therapy in both the adult and pediatric patient populations, respectively, and the third who will present on disease states in which short course therapy may not be appropriate including data which is currently emerging in this area. Finally, all speakers will address mechanisms to integrate or identify patients who would benefit or would be considered ineligible for short course antimicrobial therapy.

Faculty

Moderator: David B. Cluck, Pharm.D., BCIDP, BCPS, AAHIVP Assistant Professor, Department of Pharmacy Practice, East Tennessee State University, Gatton College of Pharmacy, Johnson City, Tennessee   View Biography